Healthcare / Health Information ServicesASX
$0.01
+0.00 (+10.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 22%
FCF escenarios
weak_data · normalized FCF $-6.6M · quality 62.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
23/100
D
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$21M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-68.9%
↓Gross Margin
99.0%
↑Debt/Equity
0.00
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+130.2%
FCF CAGR
—
FCF margin
-296.3%
FCF / Net income
0.91x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $3.1M · net income $-10.1M · FCF $-9.2M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $3.1M | $3.1M | $456914.00 | $70533.00 | $253688.00 |
| Net Income | $-10.1M | $-10.1M | $-7.4M | $-5.8M | $-6.6M |
| EBITDA | $-10.7M | $-10.7M | $-7.3M | $-5.7M | $-7.0M |
| EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Gross Margin | 99.0% | 99.0% | 100.0% | 7.0% | -2.2% |
| Operating Margin | -346.3% | -346.3% | -1673.4% | -9005.5% | -2788.0% |
| Net Margin | -326.6% | -326.6% | -1627.5% | -8188.1% | -2611.2% |
| Balance Sheet | |||||
| Debt/Equity | 0.00 | 0.00 | 0.50 | 0.18 | 0.02 |
| Current Ratio | 2.95 | 2.95 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-9.2M | $-9.2M | $-6.6M | $-4.5M | $-8.5M |
| Returns | |||||
| ROE | -68.9% | -68.9% | -286.8% | -698.4% | -220.2% |
| Valuation | |||||
| P/B | 1.05 | 1.05 | 10.20 | 32.18 | 12.35 |
| Growth & Yield | |||||
| Revenue Growth | 577.1% | 577.1% | 547.8% | -72.2% | — |
| EPS Growth | 1.4% | 1.4% | -1.4% | 20.9% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-72.5%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.01 → -0.01
Residual
-72.5%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.